MediPharm Labs Corp
LABS
Company Profile
Business description
MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically the company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.
Contact
151 John Street
BarrieONL4N 2L1
CANT: +1 705 719-7425
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
161
Stocks News & Analysis
stocks
Picking dividend shares in 2026? Here’s where to look
A new report from Morningstar shows opportunities for income investors.
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
With outstanding long-term estimates, here’s what we think of Nvidia stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,832.60 | 24.00 | -0.27% |
| CAC 40 | 8,119.02 | 51.07 | -0.63% |
| DAX 40 | 23,590.52 | 286.03 | -1.20% |
| Dow JONES (US) | 46,590.24 | 557.24 | -1.18% |
| FTSE 100 | 9,675.43 | 22.94 | -0.24% |
| HKSE | 26,384.28 | 188.18 | -0.71% |
| NASDAQ | 22,708.07 | 192.52 | -0.84% |
| Nikkei 225 | 49,667.67 | 656.24 | -1.30% |
| NZX 50 Index | 13,453.10 | 45.94 | -0.34% |
| S&P 500 | 6,672.41 | 61.70 | -0.92% |
| S&P/ASX 200 | 8,558.20 | 20.60 | -0.24% |
| SSE Composite Index | 3,972.03 | 18.46 | -0.46% |